with ARC who have existing immunological abnorma lities do not cha nge, that is to say, they do not a ppea r to get better or get worse. We do not know what will happen over the long run , ten or fiftee n years.
As of Oct ober I, 1984, the CDC reported that the numb er of cases of A IDS cont inues to double every six month s. As of November 6, 1984 , the number of cases was 6,993. We a re now undoubt edly over 7,000. The distribution of AIDS is as follows. California a nd New York are reportin g the highest number of cases. Texas, Florida, a nd New Jer sey are the second tier of states, reporting the next highest incidence of A IDS. In the third tier of sta tes a re Pennsylvania, Ohi o, Mich igan, Indian a, Iowa, Arka nsas, Virginia, Georgia , Louisian a, Colorado, Ari zona, a nd Washington. A comm on denom inat or for these sta tes is the presence of a la rge metr opolitan a rea, where the great est numb er of cases occur.
Roughl y thr ee-quarters of pat ients (a bout 72%) with AIDS are homosexual or bisexual men (in the United St ate s, not necessaril y in oth er parts of the world). Roughl y seventeen percent a re parenteral drug a busers. Roughl y four percent a re of Haiti an origin . One may a rgue that there is a significant a rea of overlap betwee n these grou ps. The epidemiological data that is accumulating on the hum a n T-Ieu kemia virus III (HTLV-III) suggests that it is important to recognize tha t some ethni c groups, becau se of their origin, may be a t greater risk than others. One percent of AIDS cases nati onwide occur in hemophiliacs; th e incidence in pat ients with hemophili a is much higher than in other risk groups. Pat ients who a re heterosexual contacts of members of other known risk groups repre sent one percen t of those wit h A IDS. Tr a nsfusion related cases account for one percent of all cases. Unknown or other a re four percent of the total; th is four percent includes pediatric patients, some who died before a ppropria te interviews a nd investigat ions could be ca rried out, a nd some for whom no risk char acteristics a re known.
Over a third (37 %) of all cases of AIDS are reported to occur in New York City. San Francisco report s twelve percent , Los Angele s eight percent , Miami four percent , a nd Newark three percent. Th ese a re figures valid through Oct ober I, 1984. AIDS is prim aril y a disease of urban a reas a nd their surro unding counties at this time.
With regard to case present at ion, those pat ients who present with Ka posi's sarcoma instead of a n opportunistic infect ion seem to have a somewhat better prognosis. Th is presenta tion is more common in those patients in the large st risk group, men who are homosexually or bisexually active.
There are no gre at surprises in the breakdown of racial a nd ethn ic stat istics, except that in a few cities there is a disproportionate percentage of AIDS in Blacks. The se cities includ e Philad elphia, Washington, and Baltimore. This may have to do with the epidemiol ogy in different populati ons in different urban a reas.
Female pat ients with AIDS a re primaril y members of the intr avenous dru g ab use risk group, or have cont act s with bisexually active men or intravenous drug a busers.
Again, there is frequentl y a n overla p between risk groups. Th e C DC cat agorizes th ese patients by their major life style risk, e.g., the y a re pred ominatel y drug abusers with litt le homosexual contact or predominately homosexually active men who infrequently abu se drug s.
AIDS is a venereal disease which is transmitted by sexual contact. Like man y venerea l diseases, it may be transmitted by the parenteral route as well. Pa renteral drug abuse, tr ansfusion of conta minated blood products, a nd blood cont amination of body secreti ons a t the time of intim ate contact may all be responsible for the spre ad of A IDS .
There is a small group of patients with AIDS who do not a ppea r to belong to a ny of the major risks groups, th at is to say, the y a re not male homosexuals a nd bisexuals, intravenous drug a busers, hemophiliacs, or Ha itian s. In that group a significa nt portion a re actually sexual contac ts of memb ers of major risk groups. Some of them are the child ren of mothers who are members of risk groups; a few of them a re children whose mothers appear to be normal, but whose fathers a re members of risk group s.
Th e older a case of A IDS is in terms of the da te of diagnosis the more likely it is that the patient will have expired . Ultimately we believe that AIDS will probabl y be a n entirel y fat al disease. Patients present ing with an opportu nistic infection, such as P. carinii pneum onia, a re usually dead with in one year of their diagnosis. The patients who live longest a re those who present with Kaposi's sarcoma a nd do not develop an opportunistic infection, at least not earl y in their cour se.
In Philadelphia the number of cases of AIDS cont inues to double each quarter. Looking a t nat ional statistics, one sees a simila rly alarming rise in cases being reported a round the country. In New York sta te half of the reported cases come from New York Cit y. Th is is a n exa mple of A IDS as primar ily a n ur ban disease (likewise in California, where two-thirds of all reported cas es come from San Fran cisco).
As of Jul y 1984, there have been 421 reported foreign cases of AIDS. The se reports a re the result of passive surveilla nce in most foreign countries. The majority of foreign cases being report ed come from Eur ope becau se th ey probabl y recognize mor e cases. AIDS is probab ly, however, a worldw ide disease.
The primar y pulm onar y infections in patient s with AIDS a re P. carinii pneum onia, pulmonary cytomega lovirus infecti ons, a nd pulmon ar y M . aviumi ntracellulare infectio ns. Mucosa l infect ions are very debilitating to the patient. They a re difficult to cont rol, make the pat ient's life misera ble, a nd may inte rfere with his nutritional status. An example is severe peri an al herpetic disease, somet hing that is a serious medi cal problem a nd make s the patient extremely uncomfor tabl e.
Centra l nervous system infections in patients with A IDS a re freque nt ly fat al. The y include toxoplasmosis, cr yptococcal mening itis, progressive multi foca l leukoence pha litis, cytomegalovirus encephalitis, and centra l nervous system aspergillosis.
C ry ptosporidiosis a nd giardias is a re common gas trointest ina l infections in pati ent s with A IDS which may cau se severe diarrhea a nd malabsorption. We can tre at the giardiasis, but it is very di ffi cult to effect ively tre at the cr yptosporidi osis. Long term par ent eral hyperal imentation is sometimes requ ired becau se of the severity of the malab sorpt ion.
C horioret initis in pat ients with A IDS is usua lly a resu lt of a cytomega lovirus infection , a lthough occasio na lly other entities may ca use this problem as well. Often th is will leave the pat ient blind.
Malign anci es which a re not recognized to produce systemic immunosuppression, but are considered to result from the immunosuppression that occurs in AI DS are Kaposi's sarcoma a nd C N S Iymphoma-a very rar e entity. The present a tion of Kaposi's sarcoma ca n be very varia ble; lesions ca n be both visceral a nd cuta neous, unl ike the usua l present at ion of Ka posi's sarco ma occurring in the otherwise older healthy male as cutaneous lower ext re mit y lesions. Typica l lesions may occur on the heel, chest, pa late, or in the gas trointes tina l tract.
Other malign anc ies a re probabl y a lso occurring with incre asing frequ ency, at least in the homosexua l a nd bisexual popul ati on. Whether or not th is is trul y relat ed to A IDS remai ns unclea r. We ca nnot presently diagn ose AIDS in a pat ient with syste mic lymph oma, which produ ces its own immunosuppression.
Rather poorly effect ive therap y is avai lable for patients with M. avium infect ions, cryptospori diosis infections, a nd Ka posi's sa rcoma. We have no therapy presently for pat ient s with progressive multifocal leukoenceph alopa th y, idiopathic ence phalopathy, cytomegalo virus infections, Epstei n-Barr virus infections, or th e renal insufficiency that occurs in five to te n percent of A IDS patients. We ca n treat th ings like cryptococcal menin gitis, but patients tend to relapse as soon as therapy is stopped. We can trea t P. carinii infecti ons, but aga in, patients tend to relap se. Also, the tr eatments themselves ofte n have serious complications, such as th e leuk openi a that may result from Bact rim w.
AIDS is a venereal and blood borne disease. It ca n be spread by sexua l contac t, as well as by contact with blood products. Wh eth er other secretions ca n tr an smit the disease is unclear at this time . In patients with AIDS Relat ed Complex, the HTLV-III virus has been found in sal iva a nd in semen.
Recommenda tions are that pat ient s who a re memb ers of known risk gro ups should not donat e blood. They should be very circumspect about sexual cont act with others. If they have A IDS, they should not have sexua l contact or at least should explain to their partner that they have A IDS . Even if a n an tibody assay for HTL V is put into use, this will not with one hundred percent efficiency guarantee the safe ty of the blood from a tr an smitt abl e agent. For this reaso n, we a re going to continue to recommend for some time that memb ers of known risk gr oups do not donate blood regard less of the avai la bility of a n a nti body assay .
Isolat ion in the hospit al of pati ent s with AIDS is directed aga inst the known mea ns of tra nsmission. Because it is a blood borne disease, patients have to be on blood a nd body fluid precau tions. In thi s hospital, becau se we still use enteric precaut ions for patients with hepati tis, we a lso use it for pat ients with AIDS. T he major ity of patients with AIDS do have symptomat ic diarrhea. Private rooms a re needed only for patients who do have prob lems with the ir enteric secret ions. In man y hospitals enteric precau tions are not routinely used.
Any contact with the blood or bodily secretions of a pati ent with A IDS is potenti a lly hazard ous. Materials that have been conta minated need to be sterilized or disposed of properl y. With the appropriate precauti ons, as is outlined in the hospit al isolation manu a l, it is perfectly safe to perform an y necessar y diagn ostic or therapeutic procedure on th ese pat ient s. Th e major logistical problem is that if you have to do hemod ialysis then that machine should be used only on pat ient s with AIDS .
HTL V-III, a retro virus, a member of a lar ge fam ily of viruses, is though t to be on fairl y good (but not a bsolute) evidence at this time to be the probabl e ca usa tive agent in AIDS. Unlike HT LV-I, which has been found in a sma ll number of pat ient s with A IDS a nd A IDS Related Com plex, this virus has been isolated from th irt y to fifty percent of patients with AIDS and some pat ient s with A IDS Related Complex. Antibody evidence of infection with this virus has been found in ninety-one percent of patients with AID S a nd ninet y-eight perc ent of patient s with AIDS Related Comp lex. Abo ut fifty percent of a populat ion of hemoph iliacs screened gave evidence of similar exposure . Between fifty to eighty percent of pat ients who were hea lthl y a nd homosexu ally or bisexua lly activ e have been found to have a ntibodies to th is agent. It has a lso been found in mothers of bab ies with AIDS, th e babie s themselves, a nd mem bers of high risk groups whose blood is known to have ca used AIDS. Oth er so called low risk gro ups have been antibody negat ive to dat e.
HTLV-III is a lymph otr opic virus th at preferentiall y infects T 4 cells. It is the loss of T4 cells tha t is lar gely felt to be responsible for the immun ologic defect in pat ient s with A IDS . Interestingly, this is a virus that prefers to infect acti vated T-cells ra ther than nonactivated T-cells. T his is probably of some importa nce becau se the lifest yle of homosexuall y a nd bisexu ally active males may mak e them more imm unologically activated. Sim ilarly, hemophiliac patients may a lso be immunologicall y tu rned on.
In foreig n countries, particularly in the Ca ribbea n nation s a nd Centra l Africa, it has been noted that fewer of the patients recognized a ppea r to be mem bers of known risk groups in the U.S. If you exami ne those patients who do not appear to be members of known risk groups, a large numb er a re heterosexually, as well as homosexuall y, promiscu ous. There does appea r to be a correla tion between multiple sexual partners in those patients a nd the likelih ood of developing AIDS. In a sma ll populatio n studied in Ce ntra l Afr ica, ther e was a high inciden ce of HTLV-III antibody in the group of prostitutes stu died. Those patients who themselves a re not promiscuou s who develop AIDS a re frequ entl y the contact of sexua lly promiscuous persons.
If HTLV-III virus is the ca use of AIDS, then we are developin g assays that can predict prior exposur e to the virus. We don't know exac tly what exposure to the HTLV-III virus mean s a t this time . Man y people who have evidence of exposure to th is virus are health y; the y a re not even minimall y symptomat ic. Some of the se people will probabl y never develop disease. Some may develop illness later. Som e patients who develop mild symptoms may not progress to more serious disease. So at this time we don't know how to use a n a nti body assay of HTL V-III virus except to scree n potential blood donors. Again , the use of the assay in this way will be help ful, but does not guar antee one hundred percent protect ion agai nst the tr ansmittab le agent.
Knowing the virus may eventu all y ena ble us to develop a vacci ne, but I suspect that progre ss in th is a rea will be much slower th an initia lly predicted. We don't know that a killed virus vaccine will be protect ive, a nd I don't think that a nyone will want to tak e a cha nce on a live attenua ted virus vaccine at th is time. Dr. Hauptman, would you comment on this case, please? S tephen Hauptman. D.G.. Professor of Medicine. Cardeza Foundation: Th ere a re two points that I would like to make. First , it has recentl y been proposed that HTLV-III , a retr ovirus, is the cau se of AIDS. A retrovirus is a n R N A virus, one that has in its genome a gene tha t controls a protein tha t we call reverse tr anscriptase. The virus infect s the cell, making its own reverse tr an scriptase. It then tak es nucleotides from the host cell and makes its own copy of DNA. Th is copy is frequent ly, but not always, incorpo rated into the DNA of the host. It ma y be integrat ed in one spot or a number of spots. In the case of AIDS and HT LV-II I, it would appear to be integrated into a number of spots.
W hat put investigators onto the study of retrovirus is a disease called feline leukemia, which is also due to a retrovirus and prod uces eit her a leukemic syndrome or an immunodeficiency syndro me-ma nifested by opportunistic infections. Secondly, HTLV-I has been highly associated with a n adult T-cell leukemia that is not found in this count ry. In the United St ate s most adult T-cell leukemi as a re not associated with HT LV-1. Patients with HTLV-I associated adult T-cell leukemia, much like feline leuk emia, frequentl y have opportunistic infections.
Last year there was a published report of HTLV-I having been isolated in a small num ber of patie nts with AIDS (I). Simultaneousl y, there was anot her report that a significa nt percentage of patients with AIDS had a ntibodies to the HTL V-I virus (2) . At th e time it was felt that HTL V-I migh t be the ca use of AIDS. As time went on, it was found th at a n increasi ngly small er number of AI DS patients had the HTLV-I virus. No w we know that the anti body to HTLV-III ha ppens to cross-reaction to HTLV-I. So, one thing we know for sure is that HTL V-I is not the ca use of A IDS. Th ese patients, by the way, have lots of viruses that ca n be isolate d.
Subsequ entl y, the HTLV-III virus was isolated in eigh ty-five percent of patients with AIDS a nd seventy-five to eight y percent of pat ient s with th e associa ted lymph node enlargement syndrome (3) . As a n asi de, the lymph node enla rgement syndrome associa ted with A IDS is frequently ca lled Pre-AIDS . I don' t like this nam e becau se only a sma ll portion with lymph node enlarge ment or wasting syndromes will act ually go on to develop A IDS . In fact , only three or four percent of these patients will develop AIDS (4) .
To show that HTLV-I II infects a cell, you have to do somet hing unusua l. You have to acti vate the cell with a mitogen . Th at was the stumbling block that kept resea rche rs from discover ing this possible ca use of AIDS sooner. First, you would tak e T-cells, activa te them with PH A, add a growth factor, a nd then in two weeks you could isolate th e virus using electro n microscopy or antibodies. It should be noted tha t if you wa it a month you get no virus; the cells all die out.
Init iall y resea rchers were unable to isolated HTLV-III or find significa nt antibody titer s in healthy homosexual males. Th is is in contrast to AIDS patients a nd those with the associat ed lymph node enlar gement syndrome , of whom at least eighty percent have been found to have significa nt antibody titer s (5) . Later report s, however, have found that between fifty to sixty percent (depending on the a rea) of health y homosexu al males will react to HTLV-III antibody (6) . Ninety percent of hemophiliacs have a ntibodies to HTLV-III. In a recent report, thi s virus was isolat ed from the semen, blood, and saliva of six out of eight healthy homosexual males (7, 8) . Although th is was a small study, if HT LV-III is the cau se of AIDS, then the implicatio n is tha t there a re a tremend ous number of ca rriers.
Wi th th at backgr ound , let's d iscuss two areas that might indicate HT LV-III is not the AID S virus . Firstl y, one reason to doubt HTLV-III as the virus tha t ca uses AIDS is that up until April 1984, atte mpts to infect chimpanze es with the AIDS viru s had been unsuccessfu l. Although these chimps did not develop AIDS, they did develop a decre ase in the T-4 to T-8 ra tio, which isn' t diagnostic. Su nlight will do the sa me to that rati o. On e of the chimps developed a transient lymph node enlargement. The y all developed a ntibodies to the HT LV-III virus. Now, more than a yea r-a nd-a -ha lf later, it has not been possible to produce a n A IDS like syndrome in chimps, despite injectin g them with HTLV-III from a n infected cell line. Th ere is a disease termed simia n AIDS, but this is only tr an smissible from a pe to ape. To da te, it has not been shown that hum an AIDS can be tran sferred to chimps.
Seco ndly, if you activate T-4 (helpe r) a nd T-8 (killer) cells in the peripheral blood, then only a sma ll percent age of T-4 cells will become infected upon exposu re to HT LV-II I. Over the past yea r, however, we have shown tha t T-8 cells a re defective in A IDS pati ent s, perh aps j ust as defect ive as T-4 even though they ar e not infected (9) .
Anot her point that is import ant is that you ca n isolate man y viruses from the A IDS a nd AR C gro ups we've been discussing. T his should foste r a healthy skepticism. For example, CMV can be isola ted with roughl y the sa me freq uency as HTLV-III in health y gay men, lymph node enlargement syndro me, a nd pati ent s with AIDS. The sa me is true for Epstein-Barr virus and ma ny kinds of herpe s viruses, as well as the a ntibody for hepat itis B viru s.
To my knowledge, no one has tried to infect activa ted T-4 a nd T-8 cells with other viruses, for exa mple, CM V and hepat itis B virus. Nei ther have other types of cells, for exam ple, smooth muscle or hea rt cells, been ac tivat ed a nd then infected with HTL V-III to see what would happ en .
I think there is enough evidence for us to be suspicious that HT LV-III migh t not be the virus. I' m not say ing that HTLV-III isn't th e virus . Ma ybe it is. But we need more evidence to be sure.
A tr eatment that we have been trying here for A IDS pa tient s is lym phocyte tran sfusions. In our exper ience, if the se infusions are given once a month they seem to prolong the lives of A IDS pa tients who have received them. Our first patient in th is program , who received his first infusion over two years ago, just died from a CNS lymphoma. He did not die from a recurrent infectio n. None of the patie nts we've transfused have had recurrences of their infect ions.
We ca n only begin to speculate on the mind-bod y connection a nd how this may influence AIDS. We know tha t in the pat ient present ed her e today that his moth er had died in the recent past. Did this make his immune system more susce ptible to AIDS ? What ever the connect ion, we a ll know how impor ta nt psychologica l a nd socia l support ca n be to A IDS pat ients. Ms. Sh indell, could you comm ent on the role of the AIDS Task Force , please? Beth Shindell , M .S .S.. A IDS Task Force: T hank you, Dr. Hauptma n. I would like to tal k to you a bout the role of the AIDS Task Force here in Philade lphia. Our orga niza tio n was founded by a sma ll group of gay profe ssionals a bout two yea rs ago . We have grown to a n orga niza tion of several hundred members that is able to provide a var iety of services.
Our orga niza tion has severa l roles . One of our funct ions is to provide service ma nagement for people with AIDS. That mean s that we have a group of social worker s who will-s-only on referral-see what the patient needs. We have buddie s who will provide dire ct services, for exa mple, groce ry shopping. We a lso have clinical psychologists, psychi atric social workers, a nd psychiatrists on our sta ff who provide direc t clinical ca re to persons with A IDS . We have ju st sta rted two support gro ups, one for persons with A IDS a nd one for their friends and families.
Another importa nt role of the A IDS Task Force is in educating the professional a nd lay comm unity a bout AIDS. We have a resea rch comm itt ee tha t keeps a breas t of the latest A IDS resea rch, as well as a n advocacy commi ttee that seeks to address the severe forms of discr imination that may be direc ted agai nst persons with AIDS. For example, at the present time there is no nur sing home in the cit y of Philadelphia that will accept someone with AIDS. Finall y, we have a sma ll fund, the John Locke Memorial Pa tient Support Fund , that can be used for persons with AIDS who a re in dire need of finan cial assista nce for housing and clothing, tr an sport ation, or other needs .
I a m glad to be a part of thi s conference. Unfortuna tely ther e a re some hospitals where our prese nce is not welcome . This may derive from a misconcepti on th at our orga niza tion is not professional in nat ure. Qu ite the contrary is tru e. Indeed , our continued success depends upon the dedicati on of outstand ing professionals like Dr . 11ft.
I would like to discuss briefly the impact of AIDS upon the gay com munity , which is the lar gest risk group. First of all, the ga y community is a pproxima tely half men a nd women. Ga y women a re not in the risk group, unless they are sexual partners with bisexual men or are IV drug a busers.
The impact of AIDS on the gay community has been tr emendous. A IDS impact s people who a re in the prime of their life and face the loss of the ir jobs, health benefits, a nd lives. Man y profound emot ions are stirred when ever there is a loss within the Task Force or the community . Becau se of this, A IDS has to some extent acted as a cohesive force in pulling the gay community togeth er .
O ne of the few positive outcomes of this disease may be the desensiti zat ion of the larger communi ty to their gay neighbors . There are people who are using the term homosexual a nd gay who never would have before .
If a nyone would like furth er informa tion about the AIDS Task Force, we have several brochures avai lable, as well as an AIDS Hotline, 2 15-232-8055 . Our address if you would like to write is: Th e Philadelphia AIDS Task Force , P.O. Box 7259, Philadelph ia, PA 19101. Jean Helz, M .D., Assistant Director, Division oj Consultatio n and Liaiso n Psychiatry: T ha nk you, Ms. Sh indell. The psychiatric concom itants of th is disease a re very impo rta nt. Wh enever you have a n illness that's seen as universally fat al occurring in young people who a re abo ut the sa me age as the ir health ca re givers , a lot of conflictua l feelings a rise. I think that one importa nt a nd potentially dangerous man ifestat ion of th is is deni al a mong health car e givers. We were ca lled to see a pat ient who com plai ned of headaches. His prim ar y care taker s felt that his head ache s were psychosomat ic based on his impend ing d ischar ge home , The patient was a n A IDS victim who was severel y ill. His head ache had no psychosomat ic features whatsoever. After we left the room, the patient had a grand ma l seizure. As it turned out, this pat ient had a eNS cryptococcal infection.
Sever al factors may have gone into th is patient's physician's inability to recognize tha t his com pla ints of headaches were related to true physical disease. Part of it was a wish th at his sym ptoms would be psychosomatic so that he could go home. In other words, the physician did not wan t to believe that the patient was as ill as he reall y was.
Another important issue is the ina bility of some physician s to even communicate the diagnosi s of AIDS to the ir patients. This is an issue that a lso arises in the tre atment of some ca ncer pat ients.
Dr. Haup tman :
There is a study that was done in which two groups of pati ent s were a nd were not told of their diagnosis of ca ncer ( 10) . Wh at they found was that the pat ients who had been told th at they had cancer lived significantly longer than the group of patients who did not know. Dr. He/z: In practice, we often suggest that eac h patie nt's physician follow the hint s that thei r patients give them. There a re patients who do not wan t to know their diagn osis a nd will block out whatever you tell them. How do you deal with telling a n AIDS pati ent that they have AIDS? Is there an y hope tha t you can offer them ? Ms. S hindell: Isn't the matt er of the pa tient knowing his own diagnosis compli cat ed by the amount of education th at has taken place amo ng high risk gro ups? I mea n, I am surprised th at in the case presented th at the patient did not know that Pneumocystis carinii is indicative of A IDS . Dr. Hauptman: No, I'm not sure tha t they get the details . A lot of my patients a re very bright a nd aware, but do not know a ny particular s about the disease, for exa mple, Pneumocystis carinii. A lot of th is information may be bur ied becau se of the tr emend ous a mount of information that is avai lable . Dr. Ball: Wh at a bout the atti tude of hospita l staff towards ta king ca re of pa tie nts with AIDS? What is that like? Dr. Murph ey: Sta ff att itude is much better than it was when we got our first few patients. T here used to be a lot of par an oia a nd panic. It var ies from floor to floor a nd unit to unit. Ms. S hindell: People who will ca re for an A IDS patient in the hospital will be reluctant to car e for them at home, perh aps becau se they feel ther e is less control over the disea se a t home. In my experienc e, the first time a nyone comes into conta ct with a n actual case of A IDS they often experience feeling s of pan ic. Dr. Ball: Wh at was it that cha nged the attitude of the staff towa rds patient s with A IDS ? Dr. Hauptman: The hospit al administra tion asked Dr. Murph ey, myself, a nd two or three other people to educa te and desensitize hospital staff, including everyone from housekeeping staff to resident s. Dr. Ball: Wh at is the life expecta ncy of someone with A IDS ? Dr. Ha uptman: In Philad elphia, two months. Eight y-five to ninety percent of patients a re dead within six months in the met ropolita n Philad elph ia area. Dr. Mur phey: Wh at happ ens with these patients is that the y get one opportunistic infect ion afte r a nother on top of a nother. Pat ient s who a re not dead af ter two months tend to have prolonged , difficult hospital courses. Th e pat ient ment ioned who had cr yptococcal meningitis is an example . He was in th e hospit al for all but a couple weeks of the last seven months of his life. Our first case was in the hospital for four months. Our second case was in the hospit al for the better part of three months before he died . If a pat ient has to be hospital ized sixty days, his or her hospit al costs may be as much as one million dollars . AIDS is a devastating disease, not only to the pa tient a nd his family, but a lso the heal th care system as a whole, which is one good a rg ument for direc ti ng our resea rch efforts agai nst this disea se. Dr. He/z: From a liaison psychia tr y sta ndpoi nt, it is clea r that A IDS is a disease that stresses every level of the hea lth ca re syste m. In university hospita ls I thi nk it is very import ant that the se patie nts have a primar y physician who coordina tes health ca re efforts . Often pa tient s ca n feel lost a mid the myriad of consulta nts who may be work ing on th ese often very difficult cases . It is very importa nt in the se cases for the pat ient to have one physician who he ca n ident ify with .
Another serious issue is the homophobia th at exists a mong some treating physician s. We ca n only hope to ide nti fy th is on a n individua l basis a nd gra dua lly convince these physicians that their a ttit ude may com promise the pat ient' s health ca re. Confe rences such as thi s are useful in providing for a n optimal level of excha nge among physicia ns and health ca re worke rs.
